PRNHX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

PRNHX Analyst Rating

Moderate Buy

118 Buy

9 Hold

0 Sell

Based on the consensus analyst ratings on 127 stocks held in PRNHX.

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

PRNHX Analyst Price Target

Average Price Target

$60.57

Based on 127 Wall Street analysts offering 12 month price targets to T. Rowe Price New Horizons Fund holdings in the last 3 months. The average price target is $60.57 with a high forecast of $73.18 and a low forecast of $49.68. The average price target represents a 20.86% change from the last price of $50.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"48":"$48","61":"$61","74":"$74","54.5":"$54.5","67.5":"$67.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":73.181,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$73.18</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":60.574,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$60.57</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":49.678,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$49.68</span>\n  </div></div>","useHTML":true}}],"tickPositions":[48,54.5,61,67.5,74],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,54.51546153846154,56.07092307692308,57.626384615384616,59.18184615384615,60.737307692307695,62.29276923076923,63.84823076923077,65.40369230769231,66.95915384615384,68.51461538461538,70.07007692307693,71.62553846153847,{"y":73.181,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,53.545692307692306,54.13138461538462,54.717076923076924,55.30276923076923,55.88846153846154,56.47415384615385,57.05984615384615,57.645538461538465,58.23123076923077,58.816923076923075,59.40261538461539,59.98830769230769,{"y":60.574,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,52.96,52.70753846153846,52.45507692307692,52.202615384615385,51.950153846153846,51.69769230769231,51.44523076923077,51.19276923076923,50.94030769230769,50.68784615384615,50.43538461538461,50.182923076923075,49.930461538461536,{"y":49.678,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":54.23,"date":1719792000000,"info":"<div>Price: <b>$54<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.86,"date":1722470400000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.73,"date":1725321600000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":57.59,"date":1727740800000,"info":"<div>Price: <b>$58<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.95,"date":1730419200000,"info":"<div>Price: <b>$59<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":63.84,"date":1733097600000,"info":"<div>Price: <b>$64<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":55.68,"date":1735776000000,"info":"<div>Price: <b>$56<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":58.3,"date":1738540800000,"info":"<div>Price: <b>$58<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.73,"date":1740960000000,"info":"<div>Price: <b>$53<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":49.46,"date":1743465600000,"info":"<div>Price: <b>$49<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":49.71,"date":1746057600000,"info":"<div>Price: <b>$50<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":51.42,"date":1748822400000,"info":"<div>Price: <b>$51<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":52.96,"date":1751328000000,"info":"<div>Price: <b>$53<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$73.18

Average Price Target$60.57

Lowest Price Target$49.68

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

PRNHX Stocks With Highest Upside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GBIO

Generation Bio Co.

2 Buy

1 Hold

0 Sell

Moderate Buy

$6.50

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DAWN

Day One Biopharmaceuticals, Inc.

8 Buy

1 Hold

0 Sell

Strong Buy

$26.88

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DYN

Dyne Therapeutics, Inc.

12 Buy

2 Hold

0 Sell

Strong Buy

$37.54

xxxxxxxxxxxxxxxxxxxxxxxxxxx

AUTL

Autolus Therapeutics

3 Buy

0 Hold

0 Sell

Strong Buy

$10.00

xxxxxxxxxxxxxxxxxxxxxxxxxxx

GPCR

Structure Therapeutics, Inc. Sponsored ADR

12 Buy

0 Hold

0 Sell

Strong Buy

$78.73

PRNHX Stocks With Highest Downside Potential

xxxxxxxxxxxxxxxxxxxxxxxxxxx

KRMN

Karman Holdings Inc.

5 Buy

0 Hold

0 Sell

Strong Buy

$38.67

xxxxxxxxxxxxxxxxxxxxxxxxxxx

VIK

Viking Holdings Ltd

7 Buy

3 Hold

0 Sell

Moderate Buy

$54.67

xxxxxxxxxxxxxxxxxxxxxxxxxxx

Marqeta, Inc.

2 Buy

6 Hold

0 Sell

Hold

$5.64

xxxxxxxxxxxxxxxxxxxxxxxxxxx

DDOG

Datadog Inc

31 Buy

6 Hold

1 Sell

Strong Buy

$143.93

xxxxxxxxxxxxxxxxxxxxxxxxxxx

TOST

Toast, Inc. Class A

11 Buy

9 Hold

0 Sell

Moderate Buy

$46.19

PRNHX Mutual Fund FAQ

What is PRNHX’s average 12-month price target, according to analysts?

Based on analyst ratings, T. Rowe Price New Horizons Fund’s 12-month average price target is 60.57.

What is PRNHX’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for PRNHX, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is PRNHX a Buy, Sell or Hold?

T. Rowe Price New Horizons Fund has a consensus rating of Moderate Buy which is based on 118 buy ratings, 9 hold ratings and 0 sell ratings.

What is T. Rowe Price New Horizons Fund’s price target?

The average price target for T. Rowe Price New Horizons Fund is 60.57. This is based on 127 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $73.18 ,the lowest forecast is $49.68. The average price target represents N/A Increase from the current price of N/A.

What do analysts say about T. Rowe Price New Horizons Fund?

T. Rowe Price New Horizons Fund’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 127 Wall Streets Analysts.

How can I buy shares of PRNHX?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing